Mechanisms underlying the beneficial effect of soy protein in improving the metabolic abnormalities in the liver and skeletal muscle of dyslipemic insulin resistant rats

European Journal of Nutrition

Volumn 54, Issue 3, 2015, Pages 407-419

  Oliva, M E ^a   Chicco, A ^a   Lombardo, Y B ^a  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

Dyslipidemia; Insulin resistance; Liver; Skeletal muscle; Soy protein

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE 6 PHOSPHATE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORTER 4; GLYCOGEN; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SLC2A4 PROTEIN, RAT; SOYBEAN PROTEIN; SREBF1 PROTEIN, RAT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SUGAR INTAKE; TRIACYLGLYCEROL;

ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; BLOOD; DIET THERAPY; DYSLIPIDEMIA; FATTY LIVER; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; METABOLISM; RAT; SKELETAL MUSCLE; SUGAR INTAKE; WEIGHT GAIN; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIETARY SUCROSE; DYSLIPIDEMIAS; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; GLUCOSE TRANSPORTER TYPE 4; GLUCOSE-6-PHOSPHATE; GLYCOGEN; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; MUSCLE, SKELETAL; PPAR ALPHA; RATS; RATS, WISTAR; SOYBEAN PROTEINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES; WEIGHT GAIN;

EID: 84939871832     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-014-0721-0     Document Type: Article

References (46)

1. Bruce KD, Hanson MA (2010) The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr 140:648–652
2. Anderson JW, Johnstone BM, Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276–282
3. Tovar AR, Murguía F, Cruz C, Hernández-Pando R, Aguilar-Salinas CA, Pedraza-Chaverri J, Correa-Rotter R, Torres N (2002) A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J Nutr 132:2562–2569
4. Torre-Villalvazo I, Tovar AR, Ramos-Barragán VE, Cerbón-Cervantes MA, Torres N (2008) Soy protein ameliorates metabolic abnormalities in liver and adipose tissue of rats fed a high fat diet. J Nutr 138:462–468
5. Bhathena SJ, Velasquez MT (2002) Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76:1191–1201
6. Mezei O, Banz WJ, Steger RW, Peluso MR (2003) Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 133:1238–1243
7. Noriega-López L, Tovar AR, Gonzalez-Granillo M, Hernández-Pando R, Escalante B, Santillán-Doherty P, Torres N (2007) Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones. J Biol Chem 282:20657–20666
8. Takahashi Y (2011) Soy protein and fish oil independently decrease serum lipid concentrations but interactively reduce hepatic enzymatic activity and gene expression involved in fatty acid synthesis in rats. Nutr Sci Vitaminol 57:56–64
9. Ascencio C, Torres N, Isoard-Acosta F, Gomez-Pérez F, Hernandez-Pando R, Tovar AR (2004) Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr 134:522–529
10. Tovar AR, Torre-Villalvazo I, Ochoa M, Elías AL, Ortíz V, Aguilar-Salinas CA, Torres N (2005) Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats. J Lipid Res 46:1823–1832
11. Nordentoft I, Jeppesen PB, Hong J, Abudula R, Hermansen K (2008) Increased insulin sensitivity and changes in the expression profile of key insulin regulatory genes and beta cell transcription factors in diabetic KKAy-Mice after feeding with a soy bean protein rich diet high in isoflavone content. J Agric Food Chem 56:4377–4385
12. Zimmermann C, Cederroth CR, Bourgoin L, Foti M, Nef S (2012) Prevention of diabetes in db/db mice by dietary soy is independent of isoflavone levels. Endocrinology 153:5200–5211
13. Moriyama T, Kishimoto K, Nagai K, Urade R, Ogawa T, Utsumi S, Maruyama N, Maebuchi M (2004) Soybean β-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of β-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride adsorption. Biosci Biotechnol Biochem 68:352–359
14. Lu J, Zeng Y, Hou W, Zhang S, Li L, Luo X, Xi W, Chen Z, Xiang M (2012) The soybean peptide aglycin regulates glucose homeostasis in type 2 diabetic mice via IR/IRS1 pathway. J Nutr Biochem 23:1449–1457
15. Lombardo YB, Chicco A (2006) Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J Nutr Biochem 17:1–13
16. Rossi AS, Lombardo YB, Chicco AG (2010) Lipogenic enzyme activities and glucose uptake in fat tissue of dyslipemic, insulin-resistant rats: effects of fish oil. Nutrition 26:209–217
17. Lavigne C, Marette A, Jacques H (2000) Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 278:E491–E500
18. Oliva ME, Chicco AG, Lombardo YB (2009) Soya protein reverses dyslipidemia and the altered capacity of insulin-stimulated glucose utilization in the skeletal muscle of sucrose-rich diet-fed rats. Brit J of Nutr 102:60–68
19. Herbert V, Lau KS, Gottlieb CH, Bleicher SJ (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375–1384
20. Lombardo YB, Chicco A, Basílico MZ, Bernal C, Gutman R (1985) Effect of brominated vegetable oils on heart lipid metabolism. Lipids 7:425–432
21. Zimmermann R, Haemmerle G, Wagner EM (2003) Decreased fatty acid esterification compensates for the reduced lipolytic activity in hormone-sensitive lipase deficient white adipose tissue. J Lipid Res 44:2089–2099
22. Rossi A, Oliva ME, Ferreira MR, Chicco A, Lombardo YB (2013) Dietary chia seed induced changes in hepatic transcription factors and their target lipogenic and oxidative enzyme activities in dyslipidemic insulin resistant rats. Br J Nutr 109:1617–1627
23. Hsu RY (1969) Malic enzyme HA. Methods Enzymol 13:230–235
24. Cohen AM, Briller S, Shafrir E (1972) Effect of long term sucrose feeding on the activity of some enzymes regulating glycolysis, lipogenesis and gluconeogenesis in rat liver and adipose tissue. Biochim Biophys Acta 279:129–138
25. Vamecq J (1990) Fluorometric assay of peroxisomal oxidase. Anal Biochem 186:340–349
26. Hein GJ, Bernasconi AM, Montanaro MA, Pellon-Maison M, Finarelli G, Chicco A, Lombardo YB, Brenner RR (2010) Nuclear receptors and hepatic lipidogenic enzyme response to a dyslipidemic sucrose-rich diet and its reversal by fish oil n-3 polyunsaturated fatty acids. Am J Physiol Endocrinol Metab 298:E429–E439
27. Karlic H, Lohninger S, Koeck T, Lohninger A (2002) L-Carnitine stimulates carnitine acyltransferases in the liver of aged rats. J Histochem Cytochem 50:205–212
28. Nakatani T, Kim HJ, Kaburagi Y, Yasuda K, Ezaki O (2003) A low fish oil inhibits SREBP-1 proteolytic cascade, while a high-fish-oil feeding decreases SREBP-1 mRNA in mice liver: relationship to anti-obesity. J Lipid Res 44:369–379
29. D’Alessandro ME, Chicco AG, Lombardo YB (2006) A long-term sucrose-rich diet increases diacylglycerol content and membrane nPKCθ expression and alters glucose metabolism in skeletal muscle of rats. Nutr Res 26(2006):289–296
30. D’Alessandro ME, Chicco A, Lombardo YB (2013) Fish oil reverses the altered glucose transporter, phosphorylation, insulin receptor substrate-1 protein level and lipid contents in the skeletal muscle of sucrose-rich diet fed rats. Prostaglandins Leukot Essent Fatty Acids 88:171–177
31. Chicco A, D’Alessandro ME, Karabatas L, Pastorale C, Basabe JC, Lombardo YB (2003) Muscle lipid metabolism and insulina secretion are altered in insulin-resistant rats fed a high sucrose diet. J Nutr 133:127–133
32. Glantz SA (2005) Primer of Biostatistic. McGraw Hill, New York
33. Snedecor GWP, Cochran WG (1967) Factorial experiments. In: Ames IA (ed) Statistical methods applied to experimental agriculture and biology. Iowa State University Press, Ames, pp 339–350
34. Oliva ME, Selenscig D, D’Alessandro ME, Chicco A, Lombardo YB (2011) Soya protein ameliorates the metabolic abnormalities of dysfunctional adipose tissue of dyslipidemic rats fed a sucrose-rich diet. Br J Nutr 105:1188–1198
35. Ronis MJ, Chen Y, Badeaux J, Badgerm TM (2009) Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR and SREBP signaling. J Nutr 139:1431–1438
36. Yamazaki T, Kishimoto K, Miura S, Ezaki O (2012) Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein. J Nutr Biochem 23:123–132
37. Kim S, Shin H, Kim SY, Kim JH, Lee YS, Kim D, Lee M (2004) Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARα. Mol Cel Endoc 220:51–58
38. Borradaile NM, de Dreu LE, Wilcox LJ, Edwards JY, Huff MW (2009) Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Biochem J 366:531–539
39. Takahashi Y, Odbayar TO, Ide T (2009) A comparative analysis of genistein and daidzein in affecting lipid metabolism in rat liver. J Clin Biochem Nutr 44:223–230
40. Peluso MR, Winters TA, Shanahan MF, Banz WJ (2000) A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats. J Nutr 130:2333–2342
41. Li Y, Soos TJ, Li X, Wu J, Degennaro M, Sun X, Littman DR, Birnbaum MJ, Polakiewicz RD (2004) Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). J Biol Chem 29:45304–45307
42. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48:1270–1274
43. Lee JS (2006) Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sci 13:1578–1584
44. Ae Park S, Choi MS, Cho SY, Seo JS, Jung UJ, Kim MJ, Sung MK, Park YB, Lee MK (2006) Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci 79:1207–1213
45. Arunkumar E, Anuradha CV (2012) Genistein promotes insulin action through adenosine monophosphate-activated protein kinase activation and p70 ribosomal protein S6 kinase 1 inhibition in the skeletal muscle of mice fed a high energy diet. Nutr Res 32:617–625
46. Cederroth CR, Vinciguerra M, Gjinovci A, Kühne F, Klein M, Cederroth M, Caille D, Suter M, Neumann D, James RW, Doerge DR, Wallimann T, Meda P, Foti M, Rohner-Jeanrenaud F, Vassalli J, Nef S (2008) Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. Diabetes 57:1176–1185